Literature DB >> 24865675

Cryptosporidiosis in HIV/AIDS patients in Kenya: clinical features, epidemiology, molecular characterization and antibody responses.

Jane W Wanyiri1, Henry Kanyi2, Samuel Maina2, David E Wang2, Aaron Steen2, Paul Ngugi2, Timothy Kamau2, Tabitha Waithera2, Roberta O'Connor2, Kimani Gachuhi2, Claire N Wamae2, Mkaya Mwamburi2, Honorine D Ward1.   

Abstract

We investigated the epidemiological and clinical features of cryptosporidiosis, the molecular characteristics of infecting species and serum antibody responses to three Cryptosporidium-specific antigens in human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients in Kenya. Cryptosporidium was the most prevalent enteric pathogen and was identified in 56 of 164 (34%) of HIV/AIDS patients, including 25 of 70 (36%) with diarrhea and 31 of 94 (33%) without diarrhea. Diarrhea in patients exclusively infected with Cryptosporidium was significantly associated with the number of children per household, contact with animals, and water treatment. Cryptosporidium hominis was the most prevalent species and the most prevalent subtype family was Ib. Patients without diarrhea had significantly higher serum IgG levels to Chgp15, Chgp40 and Cp23, and higher fecal IgA levels to Chgp15 and Chgp40 than those with diarrhea suggesting that antibody responses to these antigens may be associated with protection from diarrhea and supporting further investigation of these antigens as vaccine candidates. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24865675      PMCID: PMC4125256          DOI: 10.4269/ajtmh.13-0254

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  74 in total

1.  Nucleotide changes within three Cryptosporidium parvum surface protein encoding genes differentiate genotype I from genotype II isolates.

Authors:  Gregory D Sturbaum; B Helen Jost; Charles R Sterling
Journal:  Mol Biochem Parasitol       Date:  2003-04-25       Impact factor: 1.759

2.  Serum IgG response to Cryptosporidium immunodominant antigen gp15 and polymorphic antigen gp40 in children with cryptosporidiosis in South India.

Authors:  Sitara Swarna Rao Ajjampur; Rajiv Sarkar; Geneve Allison; Kalyan Banda; Anne Kane; Jayaprakash Muliyil; Elena Naumova; Honorine Ward; Gagandeep Kang
Journal:  Clin Vaccine Immunol       Date:  2011-02-02

3.  Prevalence and epidemiologic characteristics of opportunistic and non-opportunistic intestinal parasitic infections in HIV positive patients in Manipur.

Authors:  L Anand; C Dhanachand; N Brajachand
Journal:  J Commun Dis       Date:  1998-03

4.  The occurrence of Cryptosporidium oocysts in faecal samples submitted for routine examination at Kenyatta National Hospital.

Authors:  B B Estambale; C R Bwibo; S Kang'ethe; P M Chitayi
Journal:  East Afr Med J       Date:  1989-12

5.  Rapid increase of mucosal CD4 T cells followed by clearance of intestinal cryptosporidiosis in an AIDS patient receiving highly active antiretroviral therapy.

Authors:  W Schmidt; U Wahnschaffe; M Schäfer; T Zippel; M Arvand; A Meyerhans; E O Riecken; R Ullrich
Journal:  Gastroenterology       Date:  2001-03       Impact factor: 22.682

6.  A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes.

Authors:  L E Perryman; D P Jasmer; M W Riggs; S G Bohnet; T C McGuire; M J Arrowood
Journal:  Mol Biochem Parasitol       Date:  1996-10-01       Impact factor: 1.759

7.  Identification of Cpgp40/15 Type Ib as the predominant allele in isolates of Cryptosporidium spp. from a waterborne outbreak of gastroenteritis in South Burgundy, France.

Authors:  Seth Cohen; Frédéric Dalle; Anne Gallay; Marc Di Palma; Alain Bonnin; Honorine D Ward
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

8.  Subtype analysis of Cryptosporidium isolates from children in Uganda.

Authors:  Donna E Akiyoshi; James K Tumwine; Sabrina Bakeera-Kitaka; Saul Tzipori
Journal:  J Parasitol       Date:  2006-10       Impact factor: 1.276

9.  Quantification of specific antibody response to Cryptosporidium antigens by laser densitometry.

Authors:  B L Ungar; T E Nash
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

10.  Cryptosporidiosis-an overview.

Authors:  Gordon J Leitch; Qing He
Journal:  J Biomed Res       Date:  2012-02-21
View more
  25 in total

1.  Systemic and Mucosal Immune Responses to Cryptosporidium-Vaccine Development.

Authors:  Jacob G Ludington; Honorine D Ward
Journal:  Curr Trop Med Rep       Date:  2015-09-01

2.  Epidemiology of Cryptosporidium Infections among People Living with HIV/AIDS in Nigeria: Results of Systematic Review and Meta-analysis.

Authors:  Solomon Ngutor Karshima; Magdalene Nguvan Karshima
Journal:  Acta Parasitol       Date:  2020-07-18       Impact factor: 1.440

3.  Asparagine-Linked Glycans of Cryptosporidium parvum Contain a Single Long Arm, Are Barely Processed in the Endoplasmic Reticulum (ER) or Golgi, and Show a Strong Bias for Sites with Threonine.

Authors:  John R Haserick; Deborah R Leon; John Samuelson; Catherine E Costello
Journal:  Mol Cell Proteomics       Date:  2017-02-08       Impact factor: 5.911

4.  Cryptosporidium spp. Infection in Solid Organ Transplantation: The Nationwide "TRANSCRYPTO" Study.

Authors:  Fanny Lanternier; Karima Amazzough; Loic Favennec; Marie-France Mamzer-Bruneel; Hendy Abdoul; Jérome Tourret; Stéphane Decramer; Julien Zuber; Anne Scemla; Christophe Legendre; Olivier Lortholary; Marie-Elisabeth Bougnoux
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

5.  Highly specific detection of Cryptosporidium spp. oocysts in human stool samples by undemanding and inexpensive phase contrast microscopy.

Authors:  Ralf Ignatius; Thomas Klemm; Steffen Zander; Jean Bosco Gahutu; Peter Kimmig; Frank P Mockenhaupt; Thomas Regnath
Journal:  Parasitol Res       Date:  2015-12-08       Impact factor: 2.289

6.  Cryptosporidium parvum vaccine candidates are incompletely modified with O-linked-N-acetylgalactosamine or contain N-terminal N-myristate and S-palmitate.

Authors:  John R Haserick; Joshua A Klein; Catherine E Costello; John Samuelson
Journal:  PLoS One       Date:  2017-08-08       Impact factor: 3.240

7.  Revisiting the global problem of cryptosporidiosis and recommendations.

Authors:  Arpit Kumar Shrivastava; Subrat Kumar; Woutrina A Smith; Priyadarshi Soumyaranjan Sahu
Journal:  Trop Parasitol       Date:  2017 Jan-Jun

8.  Evaluation of possible prophylactic and therapeutic effect of mefloquine on experimental cryptosporidiosis in immunocompromised mice.

Authors:  Eman S El-Wakil; Amal E Salem; Asmaa M F Al-Ghandour
Journal:  J Parasit Dis       Date:  2020-11-13

9.  Prevalence of intestinal opportunistic parasites infections in the University hospital of Bobo-Dioulasso, Burkina Faso.

Authors:  Ibrahim Sangaré; Sanata Bamba; Mamoudou Cissé; Adama Zida; Rabila Bamogo; Constant Sirima; Bienvenue K Yaméogo; Roger Sanou; François Drabo; Roch K Dabiré; Robert T Guiguemdé
Journal:  Infect Dis Poverty       Date:  2015-07-27       Impact factor: 4.520

10.  The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS).

Authors:  Samba O Sow; Khitam Muhsen; Dilruba Nasrin; William C Blackwelder; Yukun Wu; Tamer H Farag; Sandra Panchalingam; Dipika Sur; Anita K M Zaidi; Abu S G Faruque; Debasish Saha; Richard Adegbola; Pedro L Alonso; Robert F Breiman; Quique Bassat; Boubou Tamboura; Doh Sanogo; Uma Onwuchekwa; Byomkesh Manna; Thandavarayan Ramamurthy; Suman Kanungo; Shahnawaz Ahmed; Shahida Qureshi; Farheen Quadri; Anowar Hossain; Sumon K Das; Martin Antonio; M Jahangir Hossain; Inacio Mandomando; Tacilta Nhampossa; Sozinho Acácio; Richard Omore; Joseph O Oundo; John B Ochieng; Eric D Mintz; Ciara E O'Reilly; Lynette Y Berkeley; Sofie Livio; Sharon M Tennant; Halvor Sommerfelt; James P Nataro; Tomer Ziv-Baran; Roy M Robins-Browne; Vladimir Mishcherkin; Jixian Zhang; Jie Liu; Eric R Houpt; Karen L Kotloff; Myron M Levine
Journal:  PLoS Negl Trop Dis       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.